119 related articles for article (PubMed ID: 19508621)
1. Inability of celecoxib to prevent fibrosis in bile duct-ligated rat liver.
Kapoor S; Bahde R
Liver Int; 2009 Aug; 29(7):1125; author reply 1125-6. PubMed ID: 19508621
[No Abstract] [Full Text] [Related]
2. The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.
Yu J; Hui AY; Chu ES; Go MY; Cheung KF; Wu CW; Chan HL; Sung JJ
Liver Int; 2009 Jan; 29(1):25-36. PubMed ID: 18435714
[TBL] [Abstract][Full Text] [Related]
3. [Study on the mechanism of preventing alcholic liver disease by selective cyclooxygenase 2 inhibitor].
Zhou JY; Zhou DF; Liu YH; Wang W; Wei F
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):559-60. PubMed ID: 19912698
[No Abstract] [Full Text] [Related]
4. Effect of celecoxib on experimental liver fibrosis in rat.
Hui AY; Leung WK; Chan HL; Chan FK; Go MY; Chan KK; Tang BD; Chu ES; Sung JJ
Liver Int; 2006 Feb; 26(1):125-36. PubMed ID: 16420518
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the pathogenesis of liver fibrosis induced by pig serum exposure and bile duct ligation in rats].
He Y; Chen BL; Yang RP; Ren M; Zeng ZR
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):270-4. PubMed ID: 20159698
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib induces regression of putative preneoplastic lesions in rat liver.
Arellanes-Robledo J; Márquez-Rosado L; Pérez-Carreón JI; Fattel-Fazenda S; Aguirre-García J; Villa-Treviño S
Anticancer Res; 2006; 26(2A):1271-80. PubMed ID: 16619534
[TBL] [Abstract][Full Text] [Related]
7. Chronic treatment with celecoxib reverses chronic unpredictable stress-induced depressive-like behavior via reducing cyclooxygenase-2 expression in rat brain.
Guo JY; Li CY; Ruan YP; Sun M; Qi XL; Zhao BS; Luo F
Eur J Pharmacol; 2009 Jun; 612(1-3):54-60. PubMed ID: 19356723
[TBL] [Abstract][Full Text] [Related]
8. Histological and biochemical changes induced by total bile duct ligation in the rat.
Hinz S; Franke H; Machnik G; Müller A; Dargel R
Exp Toxicol Pathol; 1997 Aug; 49(3-4):281-8. PubMed ID: 9314065
[TBL] [Abstract][Full Text] [Related]
9. Mathematical analysis of involvement ratio between central and peripheral COX-2 in rat pain models with two types of COX-2 inhibitors with different distribution, celecoxib and CIAA.
Okumura T; Sakakibara A; Murata Y; Kita Y
Eur J Pharmacol; 2008 Jan; 578(1):97-9. PubMed ID: 17716650
[TBL] [Abstract][Full Text] [Related]
10. Action of celecoxib on hepatic metabolic changes induced by the Walker-256 tumour in rats.
Acco A; Alves da Silva MH; Batista MR; Yamamoto NS; Bracht A
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):294-300. PubMed ID: 17910611
[TBL] [Abstract][Full Text] [Related]
11. Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor.
Horrillo R; Planagumà A; González-Périz A; Ferré N; Titos E; Miquel R; López-Parra M; Masferrer JL; Arroyo V; Clària J
J Pharmacol Exp Ther; 2007 Dec; 323(3):778-86. PubMed ID: 17766677
[TBL] [Abstract][Full Text] [Related]
12. Celecoxib exacerbates hepatic fibrosis and induces hepatocellular necrosis in rats treated with porcine serum.
Liu H; Wei W; Li X
Prostaglandins Other Lipid Mediat; 2009 Apr; 88(3-4):63-7. PubMed ID: 19007904
[TBL] [Abstract][Full Text] [Related]
13. The effect of celecoxib on the development of diethylnitrosamine-induced liver tumors in rats.
Galant LW; de Mattos AA; Menti E; Valiatti FB; de Mattos AZ; Porawski M; Hartmann A; Rhoden CR
Ann Hepatol; 2013; 12(3):425-33. PubMed ID: 23619259
[TBL] [Abstract][Full Text] [Related]
14. Modulation of ionizing radiation-induced G2 arrest by cyclooxygenase-2 and its inhibitor celecoxib.
Jun HJ; Kim YM; Park SY; Park JS; Lee EJ; Choi SA; Pyo H
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):225-34. PubMed ID: 19695440
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by celecoxib in cell culture: an uncertain role for cyclooxygenase-2.
Schönthal AH
Cancer Res; 2007 Jun; 67(11):5575-6; author reply 5576. PubMed ID: 17545641
[No Abstract] [Full Text] [Related]
16. Cyclooxygenase-2 inhibitor celecoxib in a rat model of hindlimb ischemia reperfusion.
Malek HA; Saleh DM
Can J Physiol Pharmacol; 2009 May; 87(5):353-9. PubMed ID: 19448733
[TBL] [Abstract][Full Text] [Related]
17. Enhanced anti-inflammatory effects of celecoxib from a transdermally applied nanoemulsion.
Shakeel F; Baboota S; Ahuja A; Ali J; Shafiq S
Pharmazie; 2009 Apr; 64(4):258-9. PubMed ID: 19435145
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib potentiates the anticancer effect of cisplatin on vulvar cancer cells independently of cyclooxygenase.
Kim SH; Kim SH; Song YC; Song YS
Ann N Y Acad Sci; 2009 Aug; 1171():635-41. PubMed ID: 19723114
[TBL] [Abstract][Full Text] [Related]
19. The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
Soni P; Shell B; Cawkwell G; Li C; Ma H
Curr Med Res Opin; 2009 Aug; 25(8):1841-51. PubMed ID: 19530981
[TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibition improves immune system homeostasis and decreases liver damage in septic rats.
Li B; Li YM; Li X; Shi B; He MY; Zhu XL; Zhou WC; Wachtel MS; Frezza E
J Surg Res; 2009 Nov; 157(1):43-7. PubMed ID: 19765729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
